These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 7544014)
1. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). McHugh RS; Ahmed SN; Wang YC; Sell KW; Selvaraj P Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8059-63. PubMed ID: 7544014 [TBL] [Abstract][Full Text] [Related]
2. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy. McHugh RS; Nagarajan S; Wang YC; Sell KW; Selvaraj P Cancer Res; 1999 May; 59(10):2433-7. PubMed ID: 10344754 [TBL] [Abstract][Full Text] [Related]
3. Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators. Brunschwig EB; Fayen JD; Medof ME; Tykocinski ML J Immunother; 1999 Sep; 22(5):390-400. PubMed ID: 10546154 [TBL] [Abstract][Full Text] [Related]
4. B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions. Wang YC; Sashidharamurthy R; Nagarajan S; Selvaraj P Immunol Lett; 2006 Jun; 105(2):185-92. PubMed ID: 16621031 [TBL] [Abstract][Full Text] [Related]
5. Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunostimulatory molecules. Poloso NJ; Nagarajan S; Bumgarner GW; Selvaraj P Vaccine; 2001 Feb; 19(15-16):2029-38. PubMed ID: 11228374 [TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of glycolipid-anchored B7-1 (CD80) from baculovirus-infected insect cells: protein transfer onto tumor cells. Nagarajan S; Selvaraj P Protein Expr Purif; 1999 Nov; 17(2):273-81. PubMed ID: 10545276 [TBL] [Abstract][Full Text] [Related]
7. Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination. Nagarajan S; Selvaraj P Vaccine; 2006 Mar; 24(13):2264-74. PubMed ID: 16376465 [TBL] [Abstract][Full Text] [Related]
8. Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model. Bozeman EN; Cimino-Mathews A; Machiah DK; Patel JM; Krishnamoorthy A; Tien L; Shashidharamurthy R; Selvaraj P Vaccine; 2013 May; 31(20):2449-56. PubMed ID: 23541884 [TBL] [Abstract][Full Text] [Related]
9. Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules. Cimino AM; Palaniswami P; Kim AC; Selvaraj P Immunol Res; 2004; 29(1-3):231-40. PubMed ID: 15181285 [TBL] [Abstract][Full Text] [Related]
10. Properties of exogenously added GPI-anchored proteins following their incorporation into cells. Premkumar DR; Fukuoka Y; Sevlever D; Brunschwig E; Rosenberry TL; Tykocinski ML; Medof ME J Cell Biochem; 2001; 82(2):234-45. PubMed ID: 11527149 [TBL] [Abstract][Full Text] [Related]
11. The functional role of B7 molecules on the induction of thymocyte activation and apoptosis. Aoki N; Inobe M; Murakami M; Abe R; Iizuka H Microbiol Immunol; 1998; 42(8):555-65. PubMed ID: 9776397 [TBL] [Abstract][Full Text] [Related]
12. Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen. Hayden MS; Grosmaire LS; Norris NA; Gilliland LK; Winberg G; Tritschler D; Tsu TT; Linsley PS; Mittler RS; Senter PD; Fell HP; Ledbetter JA Tissue Antigens; 1996 Oct; 48(4 Pt 1):242-54. PubMed ID: 8946677 [TBL] [Abstract][Full Text] [Related]
13. Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene. Gerstmayer B; Altenschmidt U; Hoffmann M; Wels W J Immunol; 1997 May; 158(10):4584-90. PubMed ID: 9144470 [TBL] [Abstract][Full Text] [Related]
14. Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development. van Broekhoven CL; Parish CR; Vassiliou G; Altin JG J Immunol; 2000 Mar; 164(5):2433-43. PubMed ID: 10679080 [TBL] [Abstract][Full Text] [Related]
15. Activation of CD4+ T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules. Razi-Wolf Z; Höllander GA; Reiser H Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2903-8. PubMed ID: 8610140 [TBL] [Abstract][Full Text] [Related]
16. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines. Fenton RG; Turcovski-Corrales SM; Taub DD J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360 [TBL] [Abstract][Full Text] [Related]
17. Expression and functional significance of an additional ligand for CTLA-4. Lenschow DJ; Su GH; Zuckerman LA; Nabavi N; Jellis CL; Gray GS; Miller J; Bluestone JA Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11054-8. PubMed ID: 7504292 [TBL] [Abstract][Full Text] [Related]
18. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Nickoloff BJ; Nestle FO; Zheng XG; Turka LA Blood; 1994 May; 83(9):2580-6. PubMed ID: 7513205 [TBL] [Abstract][Full Text] [Related]
19. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189 [TBL] [Abstract][Full Text] [Related]